Status | Study |
Recruiting |
Study Name: Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Condition: Childhood Brain Stem Neoplasm Childhood Lymphoma Childhood Date: 2016-05-23 Interventions: Drug: Entinostat Given PO |
Recruiting |
Study Name: Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma Condition: Neurofibromatosis Type 1 Date: 2015-10-20 Interventions: Device: Magnetic resonance imaging |
Active, not recruiting |
Study Name: Pomalidomide in Treating Younger Patients With Recurrent, Progressive or Refractory Central Nervous System Tumors Condition: Neurofibromatosis Type 1 Recurrent Central Nervous System Neoplasm Date: 2015-04-13 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Phase II Pegylated Interferon Condition: Juvenile Pilocytic Astrocytomas Optic Pathway Gliomas Date: 2015-01-08 Interventions: Drug: Pegylated interferon alpha-2b PEG-Intron 1mcg/kg/dose weekly through an injection under the skin o |
Withdrawn |
Study Name: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors Condition: Acoustic Schwannoma Adult Anaplastic Astrocytoma Adult Ana Date: 2014-07-16 Interventions: Radiation: gallium Ga 68-edotreotide |
Terminated |
Study Name: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas Condition: Adult Anaplastic Ependymoma Adult Anaplastic Oligodendroglioma Date: 2014-06-24 Interventions: Drug: 18F-fluoro-dihydroxyphenylalanine |
Active, not recruiting |
Study Name: Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1. Condition: Neurofibromatosis Type 1 Date: 2014-02-26 |
Active, not recruiting |
Study Name: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma Condition: Neurofibromatosis Type 1 Recurrent Childhood Pilocytic Astrocytoma Date: 2012-03-10 Interventions: Drug: Lenalidomide Given PO |
Terminated |
Study Name: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas Condition: neurofibromatosis1 (NF1) Recurrent or Progressive Optic Pathway Glioma Date: 2011-04-18 Interventions: Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will |
Withdrawn |
Study Name: Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma Condition: Optic Nerve Glioma Date: 2010-12-13 Interventions: Drug: Temozolomide Study subje |